Journals / Glokom Katarakt / 2008 / Cilt: 3 - Sayı: 1

Trabeculectomy in refractory high intraocular pressures after intravitreal triamcinolone acetonide injection

İntravitreal triamsinolon asetonid enjeksiyonu sonrası dineçli göz içi basınç yüksekliğinde trabekülektomi

Pages
29–32
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Due to the good results in eyes which that had developed refractory high IOP after IVTA injection trabeculectomy can be considered as athe first choice of therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the efficiency of trabeculectomy in eyes which that had developed high intraocular pressures (IOP) after intravitreal triamcinolone acetonide (IVTA) injection.
📊
Key Findings & Data:Then 4 mg/0.1 ml triamcinolone was injected 3.5-4 mm away from the limbus at the inferotemporal quadrant with a 27-gauge needle.
💡
Conclusion & Impact:Conclusion: Due to the good results in eyes which that had developed refractory high IOP after IVTA injection trabeculectomy can be considered as athe first choice of therapy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Göz içi basınç · Glokom · Trabekülektomi

Abstract

Purpose: To evaluate the efficiency of trabeculectomy in eyes which that had developed high intraocular pressures (IOP) after intravitreal triamcinolone acetonide (IVTA) injection. Materials and Methods: Two hundred and fifteen eyes into which IVTA had been injected due to macular edema which caused bydeveloped by different etiologies were examined. IVTA injections were performed under topical anesthesia and aseptic conditions. Then 4 mg/0.1 ml triamcinolone was injected 3.5-4 mm away from the limbus at the inferotemporal quadrant with a 27-gauge needle. The standard trabeculectomy procedure was performed in 7 eyes which that had developed high IOP and were resistant to medical therapy. Results: After IVTA injection antiglaucomatous topical therapy was initiated in 54 (25.11%) eyes. A mean interval of 147.29±59.87 days after the injection the trabeculectomy was performed in 7 eyes which that were resistant to medical therapy and in which mean IOP was 38.14±7.60 mmHg. The mean IOP was 15.71±2.21 mmHg at the third 3 months after the operation. Within the first week after the operation there were shallow anterior chambers in two eyes and choroidal detachment in one eye. Conclusion: Due to the good results in eyes which that had developed refractory high IOP after IVTA injection trabeculectomy can be considered as athe first choice of therapy.

Özet

Amaç: İntravitreal triamsinolon asetonid (İVTA) enjeksiyonu sonrası dirençli göz içi basınç (GİB) yüksekliği gelişen gözlerde trabekülektominin etkinliğini incelemek. Gereç ve Yöntem: Değişik nedenlere bağlı olarak gelişen makular ödem nedeniyle İVTA yapılan 215 göz incelendi. İVTA enjeksiyonu aseptik şartlarda topikal anesteziyle yapıldı. 4mg/0.1 ml triamsinolon 27 gauge iğneyle alt temporalde, limbustan 3.5-4 mm uzaklıktan yapıldı. Tedaviye dirençli GİB’nı yüksekliği gelişen 7 göze standart trabekülektomi yapıldı. Bulgular: İVTA enjeksiyonu sonrası 54 göze (%25.11) antiglokomatöz topikal tedavi başlandı. Tedaviye dirençli ve ortalama göz içi basınçları (GİB) 38.14±7.60 mmHg olan 7 göze enjeksiyondan ortalama 147.29±59.87 gün sonra trabekülektomi yapıldı. Ameliyat sonrası 3. ayda ortalama GİB’nı 15.71±2.21 mmHg bulundu. Cerrahi sonrası ilk hafta içinde iki gözde ön kamara darlığı ve bir gözde koroid dekolmanı görüldü. Sonuç: İVTA enjeksiyonu sonrası dirençli GİB yüksekliği gelişen gözlerde trabekülektomi alınan iyi sonuçlardan dolayı ilk seçenek olarak düşünülebilir.

🔖

Cite This Article

TAŞKAPILI, M., YILMAZLI, C., KOCABORA, S., ŞEREFOĞLU, K., GÖÇMEZ, E. (2008). Trabeculectomy in refractory high intraocular pressures after intravitreal triamcinolone acetonide injection. Glokom Katarakt, Cilt: 3 - Sayı: 1, 29–32. https://ajindex.com/articles/226857

References (15)

  1. Jonas JB: Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Acta Ophthalmol Scand. 2005;83:645-663
  2. Jonas JB, Kreissig I, Degenring R: Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative and neovascular diseases. Prog Retin Eye Res. 2005;24:587-611
  3. Bakri S, Beer PM: The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers Imaging. 2003;34:386-390
  4. Jonas JB, Kreissig I, Degengring R: Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol. 2003;87:24-27
  5. Skuta GL, Morgan RK: Corticosteroid- induced glaucoma: Ritch R, Shields MB, Krupin T, eds. The Glaucoma Mosby Co. St. Louis. 1996;2:1177-1188
  6. Jonas JB, Spandau UH, Kamppeter U, et al.: Follow-up after intravitreal triamcinolone acetonide for diabetic macular edema. Eur J Ophthalmol. 2006;16:566-572
  7. Kubota T, Okabe H, Hisatomi T, et al.: Ultrastructure of the trabecular meshwork in secondary glaucoma eyes after intravitreal triamcinolone acetonide. J Glaucoma. 2006;15:11 7-119
  8. Singh IP, Ahmad SI, Yeh D, et al.: Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection. Am J Ophthalmol. 2004;138:286-287
  9. Jonas JB, Kreissig I., Degenring R: Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide. Arch Ophthalmol. 2003;121:729-730
  10. Sivaprasad S, McCluskey F¡ Lightman S: Intravitreal steroids in the management of macular oedema. Acta Ophthalmol Scand. 2006;84:722-733
  11. Heatley CJ, Lim KS, Siriwardena D, et al.: Malignant glaucoma as a complication of intravitreal triamcinolone acetonide. Acta Ophthalmol Scand. 2006;84:712-713
  12. Beer PM, Bakri SJ, Singh RJ, et al.: Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology. 2003;110:681-686
  13. Mason JO 3, Somaiya MD, Singh RJ: Intravitreal concentration and clearance of triamcinolone acetonide in nonvitrectomized human eyes. Retina. 2004;24:900-904
  14. Clark AF, Steely HT, Dickerson JE Jr, et al.: Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues. Invest Ophthamol Vis Sci. 2001; 42:1769-1780
  15. Clark AF, Wilson K, McCartney MD, et al.: Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. Invest Ophthamol Vis S